Jamieson Wellness (TSE:JWEL) Stock Rating Cut to Sell at TD

Key Points

• TD downgraded Jamieson Wellness to “sell” from “hold” and reduced its price target to C$45.75 from C$49.00, implying just 0.70% upside from the reported share price.
• Analyst sentiment has weakened broadly: the stock has one Buy, three Hold, and one Sell rating, with an average rating of “Hold” and an average target price of C$46.07.
• JWEL traded near its 52-week high at C$45.43, while its latest quarter included C$233.84 million in revenue and C$0.46 in earnings per share.

Jamieson Wellness (TSE:JWEL - Get Free Report) was downgraded by analysts at TD from a "hold" rating to a "sell" rating in a note issued to investors on Friday, BayStreet reports. They presently have a C$45.75 target price on the stock, down from their prior target price of C$49.00. TD's target price would indicate a potential upside of 0.70% from the company's current price.

JWEL has been the subject of a number of other reports. Stifel Nicolaus downgraded Jamieson Wellness from a "buy" rating to a "hold" rating and raised their price target for the stock from C$45.00 to C$45.75 in a research note on Friday, August 7th. Canadian Imperial Bank of Commerce lowered shares of Jamieson Wellness from an "outperformer" rating to a "tender" rating and increased their price target for the stock from C$44.00 to C$45.75 in a research note on Friday, August 7th. Canaccord Genuity Group lowered shares of Jamieson Wellness from a "buy" rating to a "hold" rating and lifted their price objective for the company from C$44.50 to C$45.75 in a research note on Monday, August 10th. National Bank Financial lowered Jamieson Wellness from an "outperform" rating to a "tender" rating and lowered their price objective for the company from C$51.00 to C$45.75 in a report on Monday, August 31st. Finally, Royal Bank Of Canada downgraded Jamieson Wellness from an "outperform" rating to a "sector perform" rating and lowered their price target for the company from C$46.00 to C$45.75 in a report on Monday, August 10th. One analyst has rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Jamieson Wellness has an average rating of "Hold" and an average target price of C$46.07.

Jamieson Wellness Stock Performance

JWEL stock traded down C$0.01 during trading on Friday, reaching C$45.43. 171,309 shares of the company's stock were exchanged, compared to its average volume of 143,925. Jamieson Wellness has a 1-year low of C$32.54 and a 1-year high of C$45.88. The firm has a market cap of C$1.88 billion, a PE ratio of 24.83 and a beta of 1.41. The company's fifty day moving average price is C$44.75 and its 200-day moving average price is C$39.26. The company has a quick ratio of 1.08, a current ratio of 3.41 and a debt-to-equity ratio of 93.69.

Jamieson Wellness (TSE:JWEL - Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The company reported C$0.46 EPS for the quarter. Jamieson Wellness had a return on equity of 15.93% and a net margin of 8.92%.The company had revenue of C$233.84 million for the quarter. On average, research analysts expect that Jamieson Wellness will post 2.1438892 EPS for the current fiscal year.

Jamieson Wellness Company Profile

Jamieson Wellness Inc is engaged in the manufacturing, distributing, and marketing of branded natural health products, including vitamins, minerals, and supplements. The company operates in two segments: The Jamieson brands and The Strategic Partners. The majority of its revenue comes from the Jamieson brand segment. Some of its brands are Jamieson, Progressive, Precision, and Iron Vegan. Geographically, most of its revenue is derived from the domestic market.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.